AAPL349.18+5.35 (+1.56%) ▲|ABBV288.90+2.91 (+1.02%) ▲|ABT104.40+1.76 (+1.71%) ▲|ACN242.99-0.41 (-0.17%) ▼|ADBE246.45-3.31 (-1.33%) ▼|AMAT424.03+8.03 (+1.93%) ▲|AMD569.90-8.54 (-1.48%) ▼|AMGN458.24+6.41 (+1.42%) ▲|AMT184.31+0.56 (+0.30%) ▲|AMZN246.11-8.50 (-3.34%) ▼|AVGO344.50-7.31 (-2.08%) ▼|AXP324.21+6.27 (+1.97%) ▲|BA173.94+6.80 (+4.07%) ▲|BAC51.73+0.88 (+1.73%) ▲|BKNG150.18+2.24 (+1.51%) ▲|BLK1,171.22+13.34 (+1.15%) ▲|BMY60.68+0.11 (+0.17%) ▲|BNY149.96+1.37 (+0.92%) ▲|BRK-B543.61+3.27 (+0.61%) ▲|C126.42+2.31 (+1.86%) ▲|CAT656.78-56.60 (-7.93%) ▼|CL92.35+0.66 (+0.72%) ▲|CMCSA21.98+0.41 (+1.90%) ▲|COF208.78+3.90 (+1.90%) ▲|COP149.24+0.18 (+0.12%) ▲|COST989.27+6.54 (+0.67%) ▲|CRM231.59-10.52 (-4.35%) ▼|CSCO109.12-1.17 (-1.06%) ▼|CVS90.59+0.64 (+0.71%) ▲|CVX230.10+0.90 (+0.39%) ▲|DE659.11+18.44 (+2.88%) ▲|DHR236.92+2.85 (+1.22%) ▲|DIS110.76+1.72 (+1.57%) ▲|DUK125.60+2.03 (+1.64%) ▲|EMR170.71+3.00 (+1.79%) ▲|FDX308.94+4.36 (+1.43%) ▲|GD369.13+14.78 (+4.17%) ▲|GE312.18+11.05 (+3.67%) ▲|GEV904.82+26.79 (+3.05%) ▲|GILD161.15+1.95 (+1.22%) ▲|GM85.76+3.28 (+3.98%) ▲|GOOG283.17-38.72 (-12.03%) ▼|GOOGL285.10-39.80 (-12.25%) ▼|GS934.68+9.51 (+1.03%) ▲|HD325.65+8.09 (+2.55%) ▲|HON221.15+1.89 (+0.86%) ▲|IBM254.77+1.55 (+0.61%) ▲|INTC92.46-3.07 (-3.21%) ▼|INTU330.00+1.81 (+0.55%) ▲|ISRG447.80+3.62 (+0.82%) ▲|JNJ274.90+3.86 (+1.42%) ▲|JPM344.08+4.78 (+1.41%) ▲|KO92.30+0.57 (+0.62%) ▲|LIN499.84-8.32 (-1.64%) ▼|LLY1,371.02+82.72 (+6.42%) ▲|LMT646.44+16.69 (+2.65%) ▲|LOW204.43+6.03 (+3.04%) ▲|LRCX257.50+3.68 (+1.45%) ▲|MA635.83+25.52 (+4.18%) ▲|MCD255.36+4.86 (+1.94%) ▲|MDLZ62.09+0.22 (+0.36%) ▲|MDT96.78+2.00 (+2.11%) ▲|META629.89+17.40 (+2.84%) ▲|MMM176.37+3.57 (+2.07%) ▲|MO75.57+2.58 (+3.53%) ▲|MRK147.55+6.62 (+4.70%) ▲|MS192.58+2.45 (+1.29%) ▲|MSFT524.03-6.99 (-1.32%) ▼|MU945.99-37.24 (-3.79%) ▼|NEE82.20+1.18 (+1.46%) ▲|NFLX62.09+0.10 (+0.15%) ▲|NKE38.39+1.24 (+3.32%) ▲|NOW112.01-38.12 (-25.39%) ▼|NVDA213.52-1.87 (-0.87%) ▼|ORCL139.64-4.91 (-3.39%) ▼|PEP132.93+0.30 (+0.23%) ▲|PFE29.73+0.28 (+0.94%) ▲|PG159.01+0.75 (+0.47%) ▲|PLTR194.55-2.27 (-1.15%) ▼|PM205.74+3.10 (+1.53%) ▲|QCOM183.24+0.27 (+0.15%) ▲|RTX200.65+4.81 (+2.45%) ▲|SBUX104.56+1.36 (+1.32%) ▲|SCHW89.72+0.96 (+1.08%) ▲|SO93.07+1.55 (+1.69%) ▲|SPG214.71+3.47 (+1.64%) ▲|T21.03+0.33 (+1.59%) ▲|TMO709.33+5.18 (+0.74%) ▲|TMUS148.77+0.69 (+0.47%) ▲|TSLA405.89+1.67 (+0.41%) ▲|TXN309.48-0.35 (-0.11%) ▼|UBER65.29+0.02 (+0.02%) ▲|UNH405.79-1.31 (-0.32%) ▼|UNP299.08+1.28 (+0.43%) ▲|UPS106.50+0.88 (+0.83%) ▲|USB60.65+1.05 (+1.76%) ▲|V409.94+9.34 (+2.33%) ▲|VZ43.70+0.52 (+1.19%) ▲|WFC85.09+1.42 (+1.69%) ▲|WMT121.05+2.28 (+1.92%) ▲|XOM182.01-0.01 (-0.01%) ▼|AAPL349.18+5.35 (+1.56%) ▲|ABBV288.90+2.91 (+1.02%) ▲|ABT104.40+1.76 (+1.71%) ▲|ACN242.99-0.41 (-0.17%) ▼|ADBE246.45-3.31 (-1.33%) ▼|AMAT424.03+8.03 (+1.93%) ▲|AMD569.90-8.54 (-1.48%) ▼|AMGN458.24+6.41 (+1.42%) ▲|AMT184.31+0.56 (+0.30%) ▲|AMZN246.11-8.50 (-3.34%) ▼|AVGO344.50-7.31 (-2.08%) ▼|AXP324.21+6.27 (+1.97%) ▲|BA173.94+6.80 (+4.07%) ▲|BAC51.73+0.88 (+1.73%) ▲|BKNG150.18+2.24 (+1.51%) ▲|BLK1,171.22+13.34 (+1.15%) ▲|BMY60.68+0.11 (+0.17%) ▲|BNY149.96+1.37 (+0.92%) ▲|BRK-B543.61+3.27 (+0.61%) ▲|C126.42+2.31 (+1.86%) ▲|CAT656.78-56.60 (-7.93%) ▼|CL92.35+0.66 (+0.72%) ▲|CMCSA21.98+0.41 (+1.90%) ▲|COF208.78+3.90 (+1.90%) ▲|COP149.24+0.18 (+0.12%) ▲|COST989.27+6.54 (+0.67%) ▲|CRM231.59-10.52 (-4.35%) ▼|CSCO109.12-1.17 (-1.06%) ▼|CVS90.59+0.64 (+0.71%) ▲|CVX230.10+0.90 (+0.39%) ▲|DE659.11+18.44 (+2.88%) ▲|DHR236.92+2.85 (+1.22%) ▲|DIS110.76+1.72 (+1.57%) ▲|DUK125.60+2.03 (+1.64%) ▲|EMR170.71+3.00 (+1.79%) ▲|FDX308.94+4.36 (+1.43%) ▲|GD369.13+14.78 (+4.17%) ▲|GE312.18+11.05 (+3.67%) ▲|GEV904.82+26.79 (+3.05%) ▲|GILD161.15+1.95 (+1.22%) ▲|GM85.76+3.28 (+3.98%) ▲|GOOG283.17-38.72 (-12.03%) ▼|GOOGL285.10-39.80 (-12.25%) ▼|GS934.68+9.51 (+1.03%) ▲|HD325.65+8.09 (+2.55%) ▲|HON221.15+1.89 (+0.86%) ▲|IBM254.77+1.55 (+0.61%) ▲|INTC92.46-3.07 (-3.21%) ▼|INTU330.00+1.81 (+0.55%) ▲|ISRG447.80+3.62 (+0.82%) ▲|JNJ274.90+3.86 (+1.42%) ▲|JPM344.08+4.78 (+1.41%) ▲|KO92.30+0.57 (+0.62%) ▲|LIN499.84-8.32 (-1.64%) ▼|LLY1,371.02+82.72 (+6.42%) ▲|LMT646.44+16.69 (+2.65%) ▲|LOW204.43+6.03 (+3.04%) ▲|LRCX257.50+3.68 (+1.45%) ▲|MA635.83+25.52 (+4.18%) ▲|MCD255.36+4.86 (+1.94%) ▲|MDLZ62.09+0.22 (+0.36%) ▲|MDT96.78+2.00 (+2.11%) ▲|META629.89+17.40 (+2.84%) ▲|MMM176.37+3.57 (+2.07%) ▲|MO75.57+2.58 (+3.53%) ▲|MRK147.55+6.62 (+4.70%) ▲|MS192.58+2.45 (+1.29%) ▲|MSFT524.03-6.99 (-1.32%) ▼|MU945.99-37.24 (-3.79%) ▼|NEE82.20+1.18 (+1.46%) ▲|NFLX62.09+0.10 (+0.15%) ▲|NKE38.39+1.24 (+3.32%) ▲|NOW112.01-38.12 (-25.39%) ▼|NVDA213.52-1.87 (-0.87%) ▼|ORCL139.64-4.91 (-3.39%) ▼|PEP132.93+0.30 (+0.23%) ▲|PFE29.73+0.28 (+0.94%) ▲|PG159.01+0.75 (+0.47%) ▲|PLTR194.55-2.27 (-1.15%) ▼|PM205.74+3.10 (+1.53%) ▲|QCOM183.24+0.27 (+0.15%) ▲|RTX200.65+4.81 (+2.45%) ▲|SBUX104.56+1.36 (+1.32%) ▲|SCHW89.72+0.96 (+1.08%) ▲|SO93.07+1.55 (+1.69%) ▲|SPG214.71+3.47 (+1.64%) ▲|T21.03+0.33 (+1.59%) ▲|TMO709.33+5.18 (+0.74%) ▲|TMUS148.77+0.69 (+0.47%) ▲|TSLA405.89+1.67 (+0.41%) ▲|TXN309.48-0.35 (-0.11%) ▼|UBER65.29+0.02 (+0.02%) ▲|UNH405.79-1.31 (-0.32%) ▼|UNP299.08+1.28 (+0.43%) ▲|UPS106.50+0.88 (+0.83%) ▲|USB60.65+1.05 (+1.76%) ▲|V409.94+9.34 (+2.33%) ▲|VZ43.70+0.52 (+1.19%) ▲|WFC85.09+1.42 (+1.69%) ▲|WMT121.05+2.28 (+1.92%) ▲|XOM182.01-0.01 (-0.01%) ▼|
17.5 C
New York
Thursday, October 29, 2026

Tag: revenues

Enzo Biochem Reports Third Quarter Fiscal Year 2025 Results

FARMINGDALE, N.Y., June 16, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (OTCQX: ENZB) (“Enzo” or the “Company”) today announced financial results for the fiscal third quarter ended April 30, 2025.

Liebherr awarded 2025 Red Dot Design award for new side-by-side refrigerator-freezer with an integrated wine compartment

Liebherr USA, Co. is proud to announce that its new side-by-side refrigerator-freezer with integrated wine compartment has been honored with the prestigious 2025 Red...

Zeo Energy Corp. Reports First Quarter 2025 Financial Results

NEW PORT RICHEY, Fla., June 16, 2025 (GLOBE NEWSWIRE) -- Zeo Energy Corp. (Nasdaq: ZEO) (“Zeo”, “Zeo Energy”, or the “Company”), a Florida-based provider of residential solar and energy efficiency solutions, today reported financial results for the first quarter ended March 31, 2025.

Streamline Health® Reports Fiscal First Quarter 2025 Financial Results

ATLANTA, June 16, 2025 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (“Streamline” or the “Company”) (Nasdaq: STRM), a leading provider of solutions that enable healthcare providers to proactively address revenue leakage and improve financial performance, today announced financial results for the fiscal first quarter of 2025 which ended April 30, 2025.

Berger Montague Reminds Open Lending Corporation (NASDAQ: LPRO) Investors With Substantial Losses to Inquire About a Securities Fraud Class Action by June 30, 2025

PHILADELPHIA, June 16, 2025 /PRNewswire/ -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against Open Lending Corporation ("Open...

Verizon to report 2Q earnings July 21, 2025

NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- Verizon Communications Inc. (NYSE, Nasdaq: VZ) will report second-quarter 2025 earnings on Monday, July 21, 2025.

Trackunit Announces Closing of Investment from Goldman Sachs Alternatives and Reinvestment by Hg

AALBORG, Denmark, June 16, 2025 /PRNewswire/ -- Trackunit, a global leader in software and IoT solutions for the construction industry, today announced the closing...

Portillo’s Adds Veteran Restaurant Leader Gene Lee to Board of Directors

Former CEO Brings a Wealth of Industry Operations Expertise
Former CEO Brings a Wealth of Industry Operations Expertise

Eos Energy Successfully Closed $336M in Concurrent Offerings of Common Stock and Convertible Senior Notes, Strengthening its Balance Sheet and Creating Enhanced Financial Flexibility

Simplified capital structure bolsters ability to rapidly meet customer demand, reduce interest expense, and increase liquidity

Press Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase...

EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study

Dupixent® (dupilumab) Demonstrated Superiority Over Xolair® (Omalizumab) in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) in Patients with Coexisting Asthma in First-ever Presented Phase 4...

New late-breaking data at EAACI showed Dupixent outperformed Xolair across all primary and secondary efficacy endpoints of CRSwNP and in all asthma-related endpoints

Airbus and McGill University are driving innovation in aerospace with an agreement for experiential learning and research

The initiative will help further propel Quebec and Canadian aerospace on the world stage, thus strengthening Montréal's position as one of the major international...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsRevenues